Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07368647 · ClinicalTrials.gov registry record

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

A clinical trial of Urinary Tract Infection (Diagnosis) and Radiation Cystitis, sponsored by Rachel A. Moses.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT07368647 is a study of Urinary Tract Infection (Diagnosis) and Radiation Cystitis that is actively recruiting participants, run by Rachel A. Moses. The registered enrollment target is 100 participants, below the 392-participant average among 4 other Urinary Tract Infection (Diagnosis) trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07368647, a study of Urinary Tract Infection (Diagnosis) and Radiation Cystitis, is actively recruiting participants, sponsored by Rachel A. Moses.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Collection of urine, blood, and tissue samples from patients undergoing hyperbaric oxygen therapy

Interventions

  • OTHER Hyperbaric Oxygen Therapy

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-04-04
Est. Completion 2027-12

Sponsor

Rachel A. Moses

1 total trials

What the Registry Record Tells You About NCT07368647

The ClinicalTrials.gov registry entry for NCT07368647 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 392-participant average among 4 other Urinary Tract Infection (Diagnosis) trials with a reported enrollment target (74% lower). The listed sponsor is Rachel A. Moses, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Urinary Tract Infection (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.

NCT07368647 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT07368647 about?

NCT07368647 is a clinical study titled "Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers". Collection of urine, blood, and tissue samples from patients undergoing hyperbaric oxygen therapy

What is the current status of trial NCT07368647?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-04-04. Estimated completion is 2027-12.

What conditions does trial NCT07368647 study?

This clinical trial studies the following conditions: Urinary Tract Infection (Diagnosis), Radiation Cystitis.

What interventions are being tested in trial NCT07368647?

The interventions under investigation include: Hyperbaric Oxygen Therapy (OTHER).

Who is sponsoring clinical trial NCT07368647?

This trial is sponsored by Rachel A. Moses, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07368647 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Tract Infection (Diagnosis)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.